OXIPOR VHC Coal Tar Solution

Manufacturer
Medtech Products Inc.
Effective date
2020-07-16
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-01 23:21:08

Label at a glance#

ProductOxipor
Active ingredientCOAL TAR
Label structure10 sections

Dosage and administration

before applying, wash affectedd area to remove loose scales shake well before use use a small wad of cotton to apply apply to affected area one to four times daily or as directed by a doctor allow to air dry before contact with clothing

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Coal Tar Solution 25% (equivalent to 5% coal tar)

Purpose

OTC - PURPOSE SECTION

Controls psoriasis

Use

INDICATIONS & USAGE SECTION

relieves and helps stop the recurrence of skin and scalp itching, irritation, redness, flaking and scaling associated with psoriasis

Warnings

WARNINGS SECTION

  • For external use only
  • Flammable
  • keep away from fire and flame
  • cap bottle tightly

Do not use

OTC - DO NOT USE SECTION

  • for prolonged periods without consulting a doctor
  • this product in or around the rectum or in the genital area or groin except on the advice of a doctor
  • this product with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs unless directed to do so by a doctor

Ask a doctor before use if

OTC - ASK DOCTOR SECTION

condition covers a large area of body

When using this product

OTC - WHEN USING SECTION

  • avoid contact with eyes. If contact occurs, rinse thoroughly with water.
  • Use caution in exposing skin to sunlight after applying. This product may increase your tendency to sunburn for up to 24 hours after application.

Stop use and ask a doctor if

OTC - STOP USE SECTION

condition worsens or does not improve after regular use of this product as directed.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • before applying, wash affectedd area to remove loose scales
  • shake well before use
  • use a small wad of cotton to apply
  • apply to affected area one to four times daily or as directed by a doctor
  • allow to air dry before contact with clothing

Other information

SPL UNCLASSIFIED SECTION

  • do not chill
  • Warning: this product contains a chemical known to the Sate of California to cause cancer. Store at room temperature away from heat.

Inactive ingredients

INACTIVE INGREDIENT SECTION

alcohol, citric acid, PEG-8, polysorbate 80, water

Questions?

OTC - QUESTIONS SECTION

1-800-443-4908

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Oxipor VHC Coal Tar Solution

4.0 fl. oz (118 mL)

Oxipor VHC Coal Tar Solution 118 mL Carton
Oxipor VHC Coal Tar Solution 118 mL Carton

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Oxipor VHC Coal Tar Solution

1.9 fl. oz (56 mL)

Oxipor VHC Coal Tar Solution 56 mL Carton
Oxipor VHC Coal Tar Solution 56 mL Carton

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63029-58563029-585-24, 63029-585-19

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ebe9df33-5a98-4cfe-abf6-c142918e38727b10de04-bd04-43ef-9e47-8b6fd4e11b7f2020-07-16WarningsExact identifier
spl id: ebe9df33-5a98-4cfe-abf6-c142918e3872
spl set id: 7b10de04-bd04-43ef-9e47-8b6fd4e11b7f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.